Kyowa Kirin is an R&D-based life sciences company which strives to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies.
Our mission is to respond to the needs of patients suffering from diseases for which no effective treatments are available, their families and the healthcare professionals fighting those diseases on the front line.
Specialising in the core fields of oncology, nephrology, immunology / allergy and the central nervous system, we develop leading-edge biotechnologies, focusing on the use of antibodies, to develop and discover innovative new drugs, which Kyowa Kirin market worldwide. You can find out more here.
Kyowa Kirin is pleased to be sponsoring the MASCC/ISOO 2021 Annual Meeting June 24-26 and wish all delegates a successful, productive meeting.